4YHF | Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Paavilainen, V.O., McFarland, J.M., Taunton, J. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 | ||||||||||||
ligand | 4C9, CL, EDO, NA, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Prolonged and tunable residence time using reversible covalent kinase inhibitors., Bradshaw JM, McFarland JM, Paavilainen VO, Bisconte A, Tam D, Phan VT, Romanov S, Finkle D, Shu J, Patel V, Ton T, Li X, Loughhead DG, Nunn PA, Karr DE, Gerritsen ME, Funk JO, Owens TD, Verner E, Brameld KA, Hill RJ, Goldstein DM, Taunton J, Nat Chem Biol. 2015 May 25. doi: 10.1038/nchembio.1817. PMID:26006010 |
Data retrieval |
View 4YHF in 3D |
Visual 3D analysis of 4YHF |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4YHF |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |